Ghorai et al.
JOCFeatured Article
6-(4-Chlorophenyl)-4-hydroxy-2-phenyl-1-(toluene-4-sulfonyl)-
1,2,5,6-tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6d).
The general procedure described above was followed when the
enolate of (E)-1a (100.0 mg, 0.46 mmol) reacted with 135.0 mg of
3d (0.46 mmol) at -50 °C for 3.0 h to afford 6d (160.0 mg, 68%
yield) as a white solid: mp 145-148 °C; Rf 0.45 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3444, 3063,
2924, 1656, 1621, 1494, 1433, 1405, 1343, 1298, 1222, 1162, 1095,
1029, 993, 957, 884, 825, 751, 715, 686, 657, 578, 541; 1H NMR
(400 MHz, CDCl3) δ 1.05 (t, 3H, J = 7.1 Hz), 2.32 (dd, 1H, J =
7.1, 17.6 Hz), 2.45 (s, 3H), 2.57 (dd, 1H, J = 5.1, 17.8 Hz),
4.02-4.14 (m, 2H), 5.06-5.09 (m, 1H), 6.11 (s, 1H), 6.86-6.97
(m, 4H), 7.04-7.13 (m, 5H), 7.31 (d, 2H, J = 8.1 Hz), 7.76 (d,
2H, J = 8.3 Hz), 12.27 (s, 1H). 13C NMR (100 MHz, CDCl3) δ
13.9, 21.6, 30.8, 54.0, 54.5, 60.9, 98.1, 126.8, 127.2, 127.5, 127.8,
128.0, 128.7, 129.9, 136.5, 137.8, 139.5, 144.0, 169.9, 170.3;
HRMS (ESI) calcd for C27H27ClNO5S (M þ Hþ) 512.1298,
found 512.1296.
4-Hydroxy-6-(4-nitrophenyl)-2-phenyl-1-(toluene-4-sulfonyl)-
1,2,5,6-tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6e).
The general procedure described above was followed when the
enolate of (E)-1a (100.0 mg, 0.46 mmol) reacted with 140.0 mg
of 3e (0.46 mmol) at -50 °C for 3.0 h to afford 6e (168.2 mg,
70% yield) as a white solid: mp 175-179 °C; Rf 0.33 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3447, 2981,
1659, 1628, 1600, 1517, 1494, 1435, 1404, 1345, 1307, 1267,
1227, 1186, 1162, 1092, 1024, 1007, 987, 923, 890, 851, 802, 741,
700, 679, 654, 619,564, 547, 464; 1H NMR (400 MHz, CDCl3) δ
1.07 (t, 3H, J = 7.1 Hz), 2.38 (dd, 1H, J = 7.1, 17.8 Hz), 2.46 (s,
3H), 2.61 (dd, 1H, J = 5.4, 17.8 Hz), 4.02-4.19 (m, 2H),
5.14-5.18 (m, 1H), 6.14 (s, 1H), 7.03-7.08 (m, 3H), 7.09-7.20
(m, 4H), 7.33 (d, 2H, J = 8.0 Hz), 7.77 (d, 2H, J = 8.0 Hz), 7.84
(d, 2H, J = 8.8 Hz), 12.27 (s, 1H); 13C NMR (125 MHz,
CDCl3) δ 13.9, 21.6, 30.7, 54.2, 54.8, 61.0, 98.2, 123.1, 127.2,
127.6, 127.9, 128.2, 130.0, 136.1, 139.2, 144.3, 146.8, 169.7;
HRMS (ESI) calcd for C27H26N2O7SNa (M þ Naþ) 545.1358,
found 545.1357.
(s, 1H), 6.90-6.99 (m, 8H), 7.05-7.08 (m, 2H), 7.42-7.48 (m,
2H), 7.52-7.57 (m, 1H), 7.83 (d, 2H, J = 8.6 Hz), 12.16 (s, 1H);
13C NMR (100 MHz, CDCl3) δ 13.9, 31.2, 54.3, 55.5, 60.8,
98.1, 127.3, 127.6, 127.7, 127.8, 128.0, 129.2, 133.0, 139.3,
139.5, 169.9, 170.8; HRMS (ESI) calcd for C26H26NO5S
(M þ Hþ) 464.1531, found 464.1533.
1-Benzenesulfonyl-4-hydroxy-6-(4-methoxyphenyl)-2-phenyl-
1,2,5,6-tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6h).
The general procedure described above was followed when the
enolate of (E)-1a (100.0 mg, 0.46 mmol) reacted with 126.0 mg
of 3h (0.46 mmol) at -50 °C for 3.5 h to afford 6h (140.8 mg,
62% yield) as a white solid: mp 144-146 °C; Rf 0.32; (20%
ethyl acetate in petroleum ether); IR νmax (KBr, cm-1) 3448,
2929, 1654, 1618, 1513, 1448, 1404, 1348, 1301, 1253, 1226,
1162, 1096, 1077, 1029, 990, 880, 829, 802, 753, 738, 695, 628,
576, 551, 465.; 1H NMR (400 MHz, CDCl3) δ 0.98 (t, 3H, J =
7.1 Hz), 2.24 (dd, 1H, J = 7.1, 17.8 Hz), 2.53 (dd, 1H, J = 5.1,
17.8 Hz), 3.62 (s, 3H), 3.92-4.09 (m, 2H), 5.00-5.04 (m, 1H),
6.05 (s, 1H), 6.44 (d, 2H, J = 8.8 Hz), 6.80 (d, 2H, J = 8.3 Hz),
6.95-7.06 (m, 5H), 7.42-7.49 (m, 2H), 7.52-7.58 (m, 1H),
7.82 (d, 2H, J = 8.3 Hz), 12.18 (s, 1H); 13C NMR (100 MHz,
CDCl3) δ 13.9, 31.1, 54.1, 54.7, 55.2, 60.8, 98.0, 113.3, 127.2,
127.5, 127.6, 128.5, 128.6, 129.2, 131.1, 132.9, 139.7, 158.7,
170.0, 170.8; HRMS (ESI) for calcd C27H28NO6S (M þ Hþ)
494.1637, found 494.1633.
4-Hydroxy-2-phenyl-6-styryl-1-(toluene-4-sulfonyl)-1,2,5,6-
tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6i). The gen-
eral procedure described above was followed when the enolate
of (E)-1a (100.0 mg, 0.46 mmol) reacted with 131.0 mg of 3i
(0.46 mmol) at -50 °C for 3.0 h to afford 6i (145.9 mg, 63%
yield) as a white solid: mp 122-124 °C; Rf 0.48 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3448, 3030,
2925, 1653, 1623, 1493, 1450, 1425, 1404, 1342, 1304, 1260,
1219, 1184, 1160, 1092, 1021, 975, 917, 818, 801, 731, 695, 673,
613, 576, 551, 473; 1H NMR (400 MHz, CDCl3) δ 1.08 (t, 3H,
J = 7.1 Hz), 2.34-2.39 (m, 2H), 2.43 (s, 3H), 4.03-4.20 (m,
2H), 4.78-4.82 (m, 1H), 5.53-5.61 (m, 1H), 6.12 (s, 1H), 6.20
(d, 1H, J = 16.1 Hz), 6.83-6.91 (m, 2H), 7.12-7.23 (m, 5H),
7.25-7.30 (m, 3H),7.37 (d, 2H, J = 7.3 Hz), 7.74 (d, 2H, J =
8.3 Hz), 12.31 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 14.0,
21.5, 30.2, 53.0, 53.3, 60.8, 97.9, 126.4, 127.0, 127.1, 127.6,
128.0, 128.1, 128.2, 129.7, 129.8, 130.6, 136.0, 137.1, 140.6,
143.8, 170.3; HRMS (ESI) calcd for C29H29NO5SNa (M þ
Naþ) 526.1664, found 526.1667.
6-Furan-2-yl-4-hydroxy-2-phenyl-1-(toluene-4-sulfonyl)-1,2,5,6-
tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6j). The gen-
eral procedure described above was followed when the enolate
of (E)-1a (100.0 mg, 0.46 mmol) reacted with 115.0 mg of 3j
(0.46 mmol) at -50 °C for 3.0 h to afford 6j (141.9 mg, 66%
yield) as a white solid: mp 172-176 °C; Rf 0.46 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3449, 2979,
2924, 1656, 1495, 1452, 1409, 1379, 1350, 1302, 1227, 1185,
1163, 1093, 1028, 966, 913, 886, 810, 733, 701, 672, 621, 595,
570, 549; 1H NMR (400 MHz, CDCl3) δ 0.92 (t, 3H, J = 7.1
Hz), 2.37 (s, 3H), 2.43 (dd, 1H, J = 7.6, 18.1 Hz), 2.55 (dd, 1H,
J = 2.7, 18.3 Hz), 3.91-4.08 (m, 2H), 5.21 (d, 1H, J = 5.8 Hz),
5.78 (d, 1H, J = 3.2 Hz), 5.84-5.87 (m, 1H), 6.0 (s, 1H), 6.77 (s,
1H), 6.92-7.01 (m, 4H), 7.19-7.24 (m, 3H), 7.70 (d, 2H, J =
8.3 Hz) 12.34 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 13.9,
21.7, 28.9, 47.9, 53.1, 60.8, 97.5, 108.6, 110.2, 126.4, 127.3,
127.5, 127.6, 129.9, 137.2, 139.7, 142.2, 143.9, 150.7, 169.9,
170.4; HRMS (ESI) calcd for C25H25NO6SNa (M þ Naþ)
490.1300, found 490.1306.
4-Hydroxy-6-(4-methoxyphenyl)-2-phenyl-1-(toluene-4-sulfonyl)-
1,2,5,6-tetrahydropyridine-3-carboxylic Acid Ethyl Ester (6f).
The general procedure described above was followed when the
enolate of (E)-1a (100.0 mg, 0.46 mmol) reacted with 133.0 mg
of 3f (0.46 mmol) at -50 °C for 4.0 h to afford 6f (135.4 mg,
58% yield) as a white solid: mp 148-152 °C; Rf 0.4 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3448, 2924,
2854, 1741, 1657, 1513, 1458, 1426, 1403, 1376, 1343, 1300,
1256, 1232, 1160, 1097, 1031, 883, 813, 752, 731, 702, 686, 655,
623, 557, 465; 1H NMR (400 MHz, CDCl3) δ 0.97 (t, 3H, J =
7.1 Hz), 2.25 (dd, 1H, J = 6.6, 17.3 Hz), 2.38 (s, 3H), 2.53 (dd,
1H, J = 4.9, 17.6 Hz), 3.61 (s, 3H), 3.92-4.09 (m, 2H),
4.99-5.02 (m, 1H), 6.03 (s, 1H), 6.43(d, 2H, J = 8.8 Hz),
6.80 (d, 2H, J = 8.8 Hz), 6.93-7.04 (m, 4H), 7.19 -7.27 (m,
3H), 7.70 (d, 2H, J = 8.3 Hz), 12.20 (s, 1H); 13C NMR (125
MHz, CDCl3) δ 13.9, 21.6, 30.9, 53.9, 54.5, 55.2, 60.7, 98.0,
113.3, 126.5, 127.2, 127.5, 127.6 128.5, 129.8, 131.1, 136.8,
139.9, 143.7, 158.6, 170.1, 170.7; HRMS (ESI) calcd for
C
28H29NO6SNa (M þ Naþ) 530.1613, found 530.1618.
1-Benzenesulfonyl-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydro-
pyridine-3-carboxylic Acid Ethyl Ester (6g). The general pro-
cedure described above was followed when the enolate of
(E)-1a (100.0 mg, 0.46 mmol) reacted with 113.0 mg of 3g
(0.46 mmol) at -50 °C for 2.5 h to afford 6g (136.4 mg, 64%
yield) as a white solid: mp 184-186 °C; Rf 0.43 (20% ethyl
acetate in petroleum ether); IR νmax (KBr, cm-1) 3447, 3034,
2925, 2855, 1963, 1663, 1630, 1496, 1451, 1425, 1402, 1370,
1341, 1302, 1233, 1163, 1096, 1026, 987, 925, 882, 782, 747, 692,
629, 578, 552, 464; 1H NMR (400 MHz, CDCl3) δ 0.99, (t, 3H,
J = 7.1 Hz), 2.27 (dd, 1H, J = 7.1, 17.6 Hz), 2.56 (dd, 1H, J =
5.6, 17.8 Hz), 3.93-4.09 (m, 2H), 5.01-5.05 (m, 1H), 6.07
Ethyl 2-(4-Cyanophenyl)-4-hydroxy-6-phenyl-1-tosyl-1,2,5,6-
tetrahydropyridine-3-carboxylate (6k). The general procedure
described above was followed when the enolate of 1b (100.0 mg,
0.41 mmol) reacted with 106.0 mg of 3a (0.41 mmol) at -50 °C
for 3.5 h to afford 6k (128 mg, 62% yield) as a white solid: mp
J. Org. Chem. Vol. 75, No. 21, 2010 7069